FDA issued a Warning Letter to Medtronic, Inc. on 7/17/2012 as a result of this inspection.
483 Medtronic Neuromodulation May 2012

483 Medtronic Neuromodulation May 2012

Ryan Benedict FDA, Marissa Steinhagen FDA, April Young FDA$119.00 - Available Now

FDA investigators audited the Medtronic Neuromodulation - Minneapolis, MN, United States facility and issued 6 inspectional observations (via FDA 483) on 09 May 2012.

Product details

  • Category: Medical Devices & Rad Health / Human Drugs
  • Number of Observations: 6
  • Inspection end: 09 May 2012
  • Location: Minneapolis, United States
  • FEI: 2182207
Add To Cart